TransCode Therapeutics, Inc. · BOATS:RNAZ

TransCode Therapeutics, Inc. shareholders

As of Sep 30, 2026, 12 institutions reported holding TransCode Therapeutics, Inc., 0.58% of its shares. Largest: Yorkville Advisors Global, LP, Citadel and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Yorkville Advisors Global, LP75,7860.44%US$127KSep 30, 2026
Citadel10,2070.06%US$17,148Sep 30, 2026
Vanguard9,5270.06%US$16,006Sep 30, 2026
UBS2,6500.02%US$4,452Sep 30, 2026
Tower Research Capital LLC (TRC)1,7460.01%US$2,934Sep 30, 2026
Osaic Holdings, Inc.270<0.01%US$453Sep 30, 2026
Robinhood Markets, Inc.102<0.01%US$168Sep 30, 2026
Wells Fargo55<0.01%US$92Sep 30, 2026
SBI Securities Co., Ltd.12<0.01%US$20Sep 30, 2026
Fidelity11<0.01%US$18Sep 30, 2026
IFP Advisors, Inc8<0.01%US$13Sep 30, 2026
Northwestern Mutual Wealth Management Co1<0.01%US$2Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund8,4920.05%US$43,649May 31, 2026
Vanguard Extended Market Index Fund6,5450.04%US$40,644Jun 30, 2026
Fidelity Series Total Market Index Fund1,180<0.01%US$6,065May 31, 2026
Fidelity Total Market Index Fund510<0.01%US$2,621May 31, 2026

Big stakes

StakeStakeSharesDateFiling
CK Life Sciences Int'l., (Holdings) Inc.83.90%14.1MAug 3, 2026Schedule 13D
Unleash Immuno Oncolytics, Inc.9.94%300KJul 23, 2026Schedule 13G
YA II PN, Ltd.9.90%102KApr 15, 2026Schedule 13G
Elena Rosa Braci6.17%186KJul 23, 2026Schedule 13G
Daniel Eduardo Katzman5.16%156KJul 23, 2026Schedule 13G

TransCode Therapeutics, Inc. insider trades